View Scopus Profile

Edward W Greeno

Professor, Medicine - Hematology, Oncology, Transplant

Emailgreen048@umn.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

6 Active
32 Finished

38 results

Active
An open-label, randomised, multicentre, phase III study of irinotecanliposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine insubjects who have not previously received chemotherapy for metastatic adenocarcinom
Greeno, E. W.
Ipsen Innovation
3/24/20 → 3/31/25
Project: Research project
A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced orMetastatic Biliary Tract Cancer
Greeno, E. W.
NUCANA, INC
12/12/19 → 12/31/24
Project: Research project
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and TolerabilityStudy of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Greeno, E. W.
Incyte Corporation
4/12/19 → 4/30/21
Project: Research project
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic AdenocarcinomaTRYbeCA-1 - Trial of Eryaspase in pancreatic Cancer
Greeno, E. W.
ERYTECH PHARMA, INC
10/1/18 → 10/30/22
Project: Research project
Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects withAdvanced Gastrointestinal Malignancies
Greeno, E. W.
Polaris Pharmaceuticals, Inc.
12/1/17 → 11/30/22
Project: Research project
A Phase 3, Randomized, Double-Blind, Placebo-Controlled,
Greeno, E. W.
HALOZYME, INC.
4/28/16 → 5/31/21
Project: Research project
Finished
A Phase 2, Randomized, Double-Blind, Placebo-Controlled
Greeno, E. W.
ASTELLAS PHARMA, INC.
2/1/16 → 2/28/21
Project: Research project
A Phase 3 Randomized, Open-Label Study comparing Pexa-Ve
Greeno, E. W.
SILLAJEN USA, INC.
1/1/16 → 9/30/20
Project: Research project
Phase Ib/II study of ALT-803 in combination with gemcita
Greeno, E. W.
ALTOR BIOSCIENCE LLC
10/1/15 → 9/30/19
Project: Research project
An International, Multi-Center, Double-Blind, Randomized
Greeno, E. W.
Immunomedics, Inc.
5/12/15 → 12/31/18
Project: Research project
A Phase I/II safety, pharmacokinetic and pharmacodynamic
Greeno, E. W.
ANAEROPHARMA SCIENCE, INC.
2/3/15 → 2/28/21
Project: Research project
A Randomized, Double-Blind, Phase 3 Study of the JAK 1/2
Greeno, E. W.
Incyte Corporation
4/15/14 → 4/30/19
Project: Research project
A Phase I, Multicenter, Open label does escalation Safet
Greeno, E. W.
MINNEAMRITA THERAPEUTICS, LLC
8/8/13 → 8/30/18
Project: Research project
Feasibility Study Of An IL-2 Expressing, Attenuated Salm
Greeno, E. W.
Courante Oncology, LLC
8/1/13 → 6/30/14
Project: Research project
An Open-Label, Multicenter, extension study of NKTR-102
Greeno, E. W.
NEKTAR THERAPEUTICS
8/1/13 → 12/31/16
Project: Research project
An Open-Label, parallel-group, multicenter Phase I study
Greeno, E. W.
NEKTAR THERAPEUTICS
5/30/13 → 8/30/18
Project: Research project
A Phase II, Randomized, Multicenter Study of PEGPH20 (PE
Greeno, E. W.
HALOZYME, INC.
5/10/13 → 11/30/19
Project: Research project
A Phase 3, randomized, double-blind study with Tivantini
Greeno, E. W.
DAIICHI SANKYO PHARM DEV
5/1/13 → 8/30/18
Project: Research project
A Randomized, Double-Blind, Phase III Study of the Effic
Greeno, E. W.
EMD Serono, Inc.
5/1/13 → 5/30/18
Project: Research project
A randomized, double blind, placebo-controlled, multicen
Greeno, E. W.
BAYER HEALTHCARE PHARMACEUTICALS
2/28/13 → 2/25/18
Project: Research project
A Randomized, Double-blind, Multi-Center Phase 3
Greeno, E. W.
Polaris Pharmaceuticals, Inc.
9/27/11 → 12/30/15
Project: Research project
A Randomized Phase 2 Study of Ruxolitinib Efficacy and S
Greeno, E. W.
Incyte Corporation
8/1/11 → 8/30/16
Project: Research project
Phase 2 Placebo-controlled Double blind Trial of Dasatin
Greeno, E. W.
OTSUKA PHARMACEUTICAL DEV. & COMM., INC.
2/17/11 → 7/30/15
Project: Research project
A Randomized Phase III, Double-Blind, Placebo-Controlled
Greeno, E. W.
NOVARTIS PHARMACEUTICALS CORPORATION
7/24/10 → 3/1/13
Project: Research project
A Phase I Study of an IL-2 Expressing, Attentuated Salmo
Greeno, E. W.
BOTANIC OIL INNOVATIONS
1/30/10 → 4/30/14
Project: Research project
A Phase III Randomized, Placebo Controlled, Double Blind
Greeno, E. W.
BAYER HEALTHCARE PHARMACEUTICALS
10/13/09 → 10/31/15
Project: Research project
A Randomized, Double-Blind, Multi-Center Phase III Study
Greeno, E. W. & Gada, P.
NOVARTIS PHARMACEUTICALS CORPORATION
6/23/09 → 12/31/12
Project: Research project
A Randomized Phase III Study of Weekly ABI-007 plus Gemc
Greeno, E. W.
Abraxis BioScience, LLC
2/1/09 → 6/30/13
Project: Research project
A Phase 2b Randomized, Double Blinded, MultiCenter Trial
Greeno, E. W.
AmpliMed Corporation
1/6/09 → 10/30/10
Project: Research project
A Randomized, Open Label Multi-Center Study of Single Ag
Greeno, E. W.
SANOFI-AVENTIS US
10/31/08 → 12/31/10
Project: Research project
A Double-blinded, Randomized, Placebo-Controlled Phase I
Greeno, E. W. & Dudek, A. Z.
GlaxoSmithKline
7/31/08 → 7/31/13
Project: Research project
A Phase II Study of HyperAcute-Pancreatic Cancer Vaccine
Greeno, E. W.
NEW LINK GENETICS
6/13/08 → 6/30/18
Project: Research project
A Phase III Randomized, double blind, pacebo-controlled
Greeno, E. W.
BAYER HEALTHCARE PHARMACEUTICALS
5/20/08 → 9/30/14
Project: Research project
A Phase 2 Evaluation of the Monoclonal Antibody RAV12, i
Greeno, E. W.
TGEN DRUG DEV SVC (TD2)
9/3/07 → 10/15/08
Project: Research project
Phase 2, Multicenter, Open-Label Study of CS-1008, A Hum
Vickers, S. & Greeno, E. W.
ICON CLINICAL RESEARCH, INC.
8/14/07 → 8/31/10
Project: Research project
A randomized study of BAY 43-9006 in combination with do
Greeno, E. W.
BAYER CORP
3/15/05 → 10/31/07
Project: Research project
CPTK787/ZK 222584 Colorectal Cancer
Greeno, E. W.
NOVARTIS PHARMACEUTICALS CORPORATION
1/1/03 → 9/30/06
Project: Research project
Phase III Randomized Controlled Study Comparing Survival
Greeno, E. W.
EXIMIAS PHARM CORP
8/24/01 → 8/23/09
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.